Fertility cryostorage and cryosafety organizations expanded through technology-enabled storage, specimen tracking, strategic partnerships, cybersecurity infrastructure, and patient-centered preservation models.
As fertility care expands and more patients pursue IVF, egg freezing, embryo banking, donor services, and long-term reproductive preservation, secure storage infrastructure has become a central part of the fertility industry’s operating model.
Organizations are investing in technology-enabled specimen management, electronic witnessing, digital consents, logistics coordination, cybersecurity, redundant storage architecture, and off-site biorepository networks designed to reduce operational risk for clinics and patients. These systems increasingly support not only long-term preservation, but also clinic workflow integrity, patient trust, transport reliability, and compliance readiness.
A capital risk firm invested in Cryo Future, and the merger of TMRW and ReproTech are among the top headlines.
CryoFuture Appoints Fiore to Board After Liss Capital Investment
In January 2026, CryoFuture announced a strategic partnership with Liss Capital Partners to support national expansion and technology development. The partnership was described as a way to accelerate growth across fertility-dedicated cryostorage and transportation services, while supporting continued investment in AI-enabled biological asset storage solutions and logistics infrastructure.
The company also strengthened its governance structure in April 2026 with the appointment of Michael Fiore to its Board of Directors. CryoFuture framed the appointment as part of its broader effort to support cryostorage and transport expansion, bringing additional finance, operations, and healthcare-scaling expertise into the organization.
Operationally, CryoFuture’s platform emphasizes geographically distributed, disaster-resilient storage. The company’s location network includes facilities serving the New York/New Jersey region, Dallas, the San Francisco Bay Area, Los Angeles, San Diego, Atlanta, and Chicago, creating a multi-site model designed to support clinics across major U.S. fertility markets.
CryoFuture also maintained visibility through conference and professional engagement, including participation in the 2026 American Association of Bioanalysts conference, where the company highlighted its cryostorage and reproductive laboratory service capabilities to professionals in reproductive biology and laboratory medicine.
Fertility Billing Solution
Fertility Billing Solution sits adjacent to the cryostorage and cryosafety category as part of the broader financial and administrative infrastructure fertility clinics rely on to support high-cost, multi-step reproductive care. While cryostorage itself is a laboratory and biorepository function, the patient and clinic experience around storage increasingly depends on accurate billing, payment coordination, coverage verification, and long-term account management.
Across fertility care, recent developments in financial technology, eligibility verification, and AI-enabled revenue-cycle management show how billing workflows are becoming more integrated with clinic operations. For fertility clinics, billing platforms that understand IVF, embryo banking, cryostorage, genetic testing, bundled pricing, and self-pay workflows can help reduce administrative burden while improving patient clarity. Fertility Billing Solution’s strategic relevance in this category is tied to that operational need: as clinics scale preservation services and long-term storage programs, financial infrastructure becomes an important part of the cryostorage patient journey.
HavenCryo supports broader service model mission
In April 2026, Inception Fertility appointed Vanessa Smith as President and Chief Operating Officer, placing operational leadership across Inception’s connected fertility brands, including HavenCryo, within a broader executive structure focused on scale, patient experience, and service integration. For HavenCryo, this leadership structure supports its role as part of a larger fertility ecosystem that includes clinical care, patient support, laboratory services, and long-term preservation.
HavenCryo’s role is connected to Inception’s broader service model. Long-term reproductive tissue storage is increasingly important for patients pursuing IVF, fertility preservation before medical treatment, donor tissue use, embryo banking, and delayed family-building. As fertility networks expand, cryostorage providers connected to larger clinical ecosystems can help create more coordinated experiences for patients moving from treatment to preservation and future use.
ReproTech Merges with TMRW
ReproTech had one of the most consequential recent periods in the cryostorage and cryosafety category, driven by technology investments, digital consent integration, cybersecurity progress, and a major business combination.
In April 2026, ReproTech and TMRW Life Sciences entered into a business combination to create a technology-enabled cryostorage company in fertility. The combined organization brought together ReproTech’s off-site biorepository network with TMRW’s digital specimen-management and automated storage capabilities, while retaining the ReproTech brand and incorporating TMRW, Matcher, and Cryologix as sub-brands. ReproTech’s Brad Senstra and TMRW’s Lou Villalba stepped into the COO and CEO role of the combined venture, respectively.
The combined company reported a national footprint that included eight off-site storage facilities, more than one million frozen reproductive specimens, service relationships with roughly 75% of U.S. fertility clinics, and support for more than 50% of patient cycles. These details underscore how cryostorage is increasingly becoming a scaled, technology-enabled infrastructure category rather than a fragmented storage function.
In September 2025, ReproTech achieved HITRUST e1 certification, a cybersecurity and information-risk management milestone relevant to organizations handling sensitive reproductive health information and specimen-management data. The certification supports ReproTech’s positioning as a cryostorage provider operating at the intersection of physical specimen custody and digital health-data stewardship.
In February 2026, ReproTech partnered with EngagedMD to modernize off-site storage consent workflows for fertility clinics. The integration allows clinics to incorporate ReproTech’s storage consent process into EngagedMD’s electronic form and patient-journey management ecosystem, reducing manual administration and improving consistency in off-site storage documentation.
Was Your Org Not Included?
Don't let your company miss out again.
Your company may have missed out on this coverage of your category before ESHRE, but Inside Reproductive Health overviews your category 4x per year.
Your competitors were covered because they are IVF Heroes Universe sponsors.
Don't miss out on the next coverage of your category--released before ASRM.
Over 60 leading fertility companies are leaders in the IVF Heroes Universe, isn't yours?
Year-long sponsorship is only $2,295 for the entire year, but get in now, before prices go up.